Skip to content

Cardiotoxicity of Aluminum Phosphide Poisoning; Tropinin and CKmb as Early Biomarkers

Cardiotoxicity of Aluminum Phosphide Poisoning; Biochemical and Electrophysiological Studies and the Utility of Tropinin and CKmb as Early Biomarkers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04191265
Enrollment
60
Registered
2019-12-09
Start date
2019-12-05
Completion date
2020-06-05
Last updated
2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aluminum Phosphid Poisoning, Cardiotoxicity

Keywords

tropinin, CKmb, cardiotoxicity

Brief summary

Aluminum phosphide (AlP) or rice tablet is a cheap pesticide. When it comes in contact with acid (gastric acid) or moisture, it releases phosphine (PH3) gas. The heart,lungs, liver are the main targets in acute Aluminum phosphide (AlP) poisoning. Most deaths occur due to cardiovascular toxicity.

Detailed description

Aluminium phosphide is a potent respiratory chain enzyme inhibitor. Its most important effect is the inhibition of cytochrome c oxidase. The inhibition of cytochrome c oxidase and other enzymes leads to the generation of superoxide radicals and cellular peroxides , and subsequent cellular injury through lipid peroxidation and other oxidant mechanisms. It stimulates the production of hydrogen peroxide and reactive oxygen species, malonyldialdehyde (MAD), increases superoxide dismutase and inhibits catalase, peroxidase and glutathione . Oxidative stress is one of the main mechanisms of action of aluminium phosphide toxicity

Interventions

DIAGNOSTIC_TESTserum tropinin, serum CKmb

early detection of myocardial injury, allowing application of acute cardiac shock and cardiogenic shock

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

ALP poisoned cases * admitted with free ECG

Exclusion criteria

concomitant ingesion of other drugs or toxins \-

Design outcomes

Primary

MeasureTime frameDescription
assess serum tropinin and CKmb as biomarkers for early detection of ALP induced myocardial injury6 monthsassess serum tropinin and CKmb as biomarkers for early detection of ALP induced myocardial injury

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026